The central roles of ATM and ATR in genome maintenance suggest the potential to manipulate their activity for cancer chemotherapy, fueling the development of potent small molecules that specifically inhibit ATM and ATR activities in cellulo[12], [13]. Here, ATR is linked to cancer.